← FDA Drug Approvals (Drugs@FDA)

OSELTAMIVIR PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-02-27

Drug application

FDA Application #

ANDA211125

Application type

Abbreviated New Drug Application (Generic)

Brand name

OSELTAMIVIR PHOSPHATE

Generic name

OSELTAMIVIR PHOSPHATE

Active ingredients

OSELTAMIVIR PHOSPHATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2019-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown